REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,822,018 | +20.8% | 1,419,900 | 0.0% | 14.38% | -12.1% |
| Q3 2022 | $28,000,000 | +1.2% | 1,419,900 | 0.0% | 16.36% | -10.1% |
| Q2 2022 | $27,674,000 | -23.6% | 1,419,900 | 0.0% | 18.20% | +37.1% |
| Q1 2022 | $36,222,000 | +1.4% | 1,419,900 | 0.0% | 13.27% | +29.1% |
| Q4 2021 | $35,739,000 | -8.5% | 1,419,900 | 0.0% | 10.28% | +16.0% |
| Q3 2021 | $39,061,000 | -13.3% | 1,419,900 | 0.0% | 8.86% | -58.7% |
| Q2 2021 | $45,068,000 | -30.8% | 1,419,900 | 0.0% | 21.46% | -10.6% |
| Q1 2021 | $65,145,000 | +15.9% | 1,419,900 | 0.0% | 24.00% | +33.1% |
| Q4 2020 | $56,214,000 | +13.8% | 1,419,900 | 0.0% | 18.03% | +6.0% |
| Q3 2020 | $49,413,000 | +10.2% | 1,419,900 | 0.0% | 17.01% | -17.6% |
| Q2 2020 | $44,826,000 | +44.1% | 1,419,900 | 0.0% | 20.65% | -27.4% |
| Q1 2020 | $31,110,000 | – | 1,419,900 | – | 28.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |